Evidence map›Paper›PMID 40710208›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

Report from the 26th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Hepatocellular and Biliary Tract Cancer, Saskatoon, Saskatchewan, 17-18 October 2024.

Deepti Ravi, Shahid Ahmed, Blaire Anderson, Brady Anderson, Bryan Brunet, Haji Chalchal, Arun Elangovan, Georgia Geller, Vallerie Gordon, Branawan Gowrishankar and 13 more

Abstract readConsensus Statement
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Deepti RaviSaskatchewan Health Authority, Saskatoon, SK S7K 0M7, Canada.
Shahid AhmedSaskatoon Cancer Centre, Saskatoon, SK S7N 4H4, Canada.ORCID 0000-0002-2099-698X
Blaire AndersonCollege of Medicine, University of Alberta, Edmonton, AB T6G 2B7, Canada.
Brady AndersonWestern Manitoba Cancer Center, Brandon, MB R7A 5M8, Canada.
Bryan BrunetSaskatoon Cancer Centre, Saskatoon, SK S7N 4H4, Canada.
Haji ChalchalAllan Blair Cancer Centre, Regina, SK S4T 7T1, Canada.ORCID 0000-0002-9388-150X
Arun ElangovanSaskatoon Cancer Centre, Saskatoon, SK S7N 4H4, Canada.
Georgia GellerBC Cancer Centre, Victoria, BC V8R 6V5, Canada.
Vallerie GordonSaskatoon Cancer Centre, Saskatoon, SK S7N 4H4, Canada.ORCID 0009-0004-6414-0018
Branawan GowrishankarCross Cancer Institute, Alberta Health Services, Edmonton, AB T6G 1Z2, Canada.
Edward HardyBC Cancer Centre, Vernon, BC V1T 5L2, Canada.
Mussawar IqbalAllan Blair Cancer Centre, Regina, SK S4T 7T1, Canada.
Duc LeSaskatoon Cancer Centre, Saskatoon, SK S7N 4H4, Canada.
Richard Lee-YingTom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.
Shazia MahmoodAllan Blair Cancer Centre, Regina, SK S4T 7T1, Canada.
Karen MulderCross Cancer Institute, Alberta Health Services, Edmonton, AB T6G 1Z2, Canada.ORCID 0000-0002-6832-0081
Maged NashedCancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Killian NewmanFoothills Medical Centre, Calgary, AB T2N 2T9, Canada.
Maurice OgaickCollege of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5A2, Canada.
Vibhay PareekCancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Jennifer RauwCross Cancer Institute, Alberta Health Services, Edmonton, AB T6G 1Z2, Canada.
Ralph WongCancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Adnan ZaidiSaskatoon Cancer Centre, Saskatoon, SK S7N 4H4, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 26th annual Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) was held in Saskatoon, Saskatchewan, on 17-18 October 2024. The WCGCCC is an interactive multidisciplinary conference that was attended by healthcare professionals from across Western Canada (British Columbia, Alberta, Saskatchewan, and Manitoba) who are involved in the care of patients with hepatocellular and biliary tract cancers. Specialists from the fields of medical and radiation oncology, interventional radiology, pathology and laboratory medicine, and general and hepatobiliary surgery participated in presentations and discussions for the purpose of developing the recommendations presented here. This consensus statement addresses current issues in the management of hepatocellular and biliary tract cancers.

Indexed as

Biliary Tract NeoplasmsCarcinoma, HepatocellularLiver NeoplasmsCanadaHumansSaskatchewanadjuvant chemoradiationadjuvant radiation therapyadjuvant systemic therapybiliary tract cancercholangiocarcinomaextrahepatic cholangiocarcinomagallbladder adenocarcinomahepatectomyhepatocellular carcinomaHER2intrahepatic cholangiocarcinomaMMRmolecular profilingsystemic therapy

Identifiers

PMID40710208
PMCPMC12293958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.